help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitagawa, Y.
Right arrow Articles by Daya, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitagawa, Y.
Right arrow Articles by Daya, M.

Am. J. Respir. Cell Mol. Biol., Vol 15, No. 1, 07 1996, 45-54.

Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers

Y Kitagawa, F Wong, P Lo, M Elliott, LM Verburgt, JC Hogg and M Daya
University of British Columbia, Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, Canada.

We investigated expression of Bcl-2, mutations in p53, and K-ras oncogene in 51 resected human non-small cell lung cancers. The studies were designed to test for the possibility of cooperativity between these oncogenes and p53 in the pathogenesis of lung cancer. An inverse relationship was found between expression of Bcl-2 and mutant p53 by immunohistochemistry (P < 0.01; Fisher exact test), suggesting that either Bcl-2 overexpression or mutations in p53 may fulfill a critical function in the pathogenesis of human non-small cell lung cancers. Tumors that harbored K-ras codon 12 mutations seldom had p53 mutations or overexpressed Bcl-2. Statistical analysis of these data showed that mutations in p53 and K-ras or overexpression of Bcl-2 and mutations in K-ras occurred at a frequency that could be explained only by chance [P > 0.1 in each case (Fisher exact tests)]. This suggests that cooperativity between mutant K-ras and mutant p53 or mutant K-ras and overexpressed Bcl-2 is not a common mechanism in the pathogenesis of human non-small cell lung cancers.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
B. Lee, G. Q. Butcher, K. R. Hoyt, S. Impey, and K. Obrietan
Activity-Dependent Neuroprotection and cAMP Response Element-Binding Protein (CREB): Kinase Coupling, Stimulus Intensity, and Temporal Regulation of CREB Phosphorylation at Serine 133
J. Neurosci., February 2, 2005; 25(5): 1137 - 1148.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Laudanski, W. Niklinska, T. Burzykowski, L. Chyczewski, and J. Niklinski
Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer
Eur. Respir. J., April 1, 2001; 17(4): 660 - 666.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
W.-Y. Chan, K.-K. Cheung, J. O. Schorge, L.-W. Huang, W. R. Welch, D. A. Bell, R. S. Berkowitz, and S. C. Mok
Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers
Am. J. Pathol., February 1, 2000; 156(2): 409 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C.-l. Huang, N. Kohno, H. Inufusa, K. Kodama, T. Taki, and M. Miyake
Overexpression of bax Associated with Mutations in the Loop-Sheet-Helix Motif of p53
Am. J. Pathol., September 1, 1999; 155(3): 955 - 965.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. A. Ahrendt, S. Halachmi, J. T. Chow, L. Wu, N. Halachmi, S. C. Yang, S. Wehage, J. Jen, and D. Sidransky
Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
PNAS, June 22, 1999; 96(13): 7382 - 7387.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 1996 American Thoracic Society.